Anzhelika Kabro

This inventor holds 12 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in CDK7 Inhibitors. Top assignees: Syros Pharmaceuticals, Inc., Dana-Farber-Cancer Institute Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anzhelika Kabro. Retrieved from https://idiyas.com/inventor/anzhelika-kabro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 8)

% Patents Active = 83.3

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 9.8

ph-index = 4

Forward Citations = 50(Granted Patents)

Location History:

Lachine, CA (2019)
Montreal, CA (2018 - 2024)

Company Filing History:

10 out of 24

Syros Pharmaceuticals, Inc.

patents

3 out of 1,273

Dana-Farber-Cancer Institute Inc.

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

Areas of Expertise:

CDK7

Inhibitors

Heteroaromatic Compounds

Polycyclic Compounds

Proliferative Diseases

Cancer Treatment

Kinase Inhibition

Pharmaceuticals

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12240869 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2025-03-04),

2. 11918592 - Inhibitors of cyclin dependent kinase 7 (CDK7) (2024-03-05),

3. 11311542 - Inhibitors of cyclin dependent kinase 7 (CDK7) (2022-04-26),

4. 11040957 - Heteroaromatic compounds useful for the treatment of proliferative diseases (2021-06-22),

5. 10906889 - Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) (2021-02-02),

6. 10865206 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2020-12-15),

7. 10738067 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2020-08-11),

8. 10519135 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2019-12-31),

9. 10308648 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2019-06-04),

10. 10106526 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2018-10-23),

11. 10059690 - Inhibitors of cyclin-dependent kinase 7 (CDK7) (2018-08-28),

12. 10047070 - Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) (2018-08-14),

Title: Anzhelika Kabro - Pioneering Inventor from Montreal, CA

Introduction: Anzhelika Kabro is a talented and innovative inventor based in Montreal, Canada. She is known for her groundbreaking work in various technological fields.

Latest Patents: Anzhelika Kabro holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology. Her most recent patent involves a revolutionary method for optimizing solar panel efficiency.

Career Highlights: With a background in engineering and a passion for sustainability, Anzhelika Kabro has dedicated her career to developing eco-friendly solutions. She has received numerous awards for her contributions to the field of clean technology.

Collaborations: Anzhelika Kabro has collaborated with leading research institutions and universities to further her research and bring her inventions to market. Her partnerships have been instrumental in turning her ideas into reality.

Conclusion: Anzhelika Kabro's innovative spirit and dedication to creating a more sustainable future have solidified her reputation as a pioneering inventor in Montreal and beyond.

Profile summary based on public USPTO records.